A detailed history of Bsw Wealth Partners transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Bsw Wealth Partners holds 22,090 shares of TAK stock, worth $305,946. This represents 0.05% of its overall portfolio holdings.

Number of Shares
22,090
Previous 19,098 15.67%
Holding current value
$305,946
Previous $247,000 26.72%
% of portfolio
0.05%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$13.0 - $15.08 $38,896 - $45,119
2,992 Added 15.67%
22,090 $313,000
Q2 2024

Jul 16, 2024

SELL
$12.6 - $13.67 $41,983 - $45,548
-3,332 Reduced 14.86%
19,098 $247,000
Q1 2024

Apr 23, 2024

BUY
$13.89 - $15.04 $71,602 - $77,531
5,155 Added 29.84%
22,430 $311,000
Q4 2023

Jan 25, 2024

BUY
$13.36 - $15.43 $4,154 - $4,798
311 Added 1.83%
17,275 $246,000
Q3 2023

Oct 27, 2023

SELL
$15.03 - $16.32 $183,125 - $198,842
-12,184 Reduced 41.8%
16,964 $262,000
Q2 2023

Aug 11, 2023

SELL
$15.57 - $17.11 $8,532 - $9,376
-548 Reduced 1.85%
29,148 $457,000
Q1 2023

May 15, 2023

SELL
$15.28 - $16.48 $186,706 - $201,369
-12,219 Reduced 29.15%
29,696 $489,000
Q4 2022

Feb 13, 2023

BUY
$12.42 - $15.62 $276,456 - $347,685
22,259 Added 113.24%
41,915 $654,000
Q3 2022

Nov 14, 2022

SELL
$12.8 - $28.65 $187,712 - $420,152
-14,665 Reduced 42.73%
19,656 $255,000
Q2 2022

Aug 15, 2022

BUY
$13.12 - $15.03 $67,948 - $77,840
5,179 Added 17.77%
34,321 $482,000
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $142,115 - $161,113
10,496 Added 56.29%
29,142 $417,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $34,307 - $42,721
2,605 Added 16.24%
18,646 $254,000
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $38,093 - $40,336
2,337 Added 17.05%
16,041 $263,000
Q2 2021

Aug 16, 2021

BUY
$16.55 - $18.64 $21,415 - $24,120
1,294 Added 10.43%
13,704 $231,000
Q1 2021

May 17, 2021

BUY
$16.71 - $19.9 $207,371 - $246,958
12,410 New
12,410 $227,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Bsw Wealth Partners Portfolio

Follow Bsw Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.